Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
This is a proof-of-concept spectroscopic study with no sample size reported, no clinical validation, no comparator performance data, and no independent replication—it raises mechanistic and diagnostic questions rather than answering them.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
This is a proof-of-concept study of a novel diagnostic probe in an animal model; it demonstrates technical feasibility and agreement with a commercial standard but lacks clinical validation in human subjects.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
Early-stage structure-activity study of novel synthetic compounds with in vitro cytotoxicity data but no in vivo validation, mechanistic proof of PDT efficacy, or clinical translation.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
Systematic review of 50 studies shows FTIR has strong potential for microbial identification and diagnosis but requires standardization and validation before clinical implementation.